ÖÆÒ©¹¤³Ì¹æ·¶Ð¡Ôý

 ÖйúаæGMP
 ÎÀ Éú²¿µÚ79ºÅÁî |
 ÖÐ ¹úGMP2011ÕýÎÄ |
 ¸½ ¼1 ÎÞ¾úÒ©Æ· |
 ¸½ ¼2 Ô­ÁÏÒ© |
 ¸½ ¼3 ÉúÎïÖÆÆ· |
 ¸½ ¼4 ѪҺÖÆÆ· |
 ¸½ ¼5 ÖÐÒ©ÖƼÁ |
¸½ ¼9 ·ÅÉäÐÔÒ©Îï |
 GMP (2010)Ó¢ÎÄ°æ |
 CFDA GMP(2010)Ë«Óï |
 Annex 1:Sterile Medicinal ProductsË«Óï |
 
Annex 2: Active Substances Used As Starting Materials |
 
Annex 3: Biological MedicinalË«Óï |
 
Annex 4: Blood ProductsË«Óï |
 
Annex 5: Chinese Medicine PreparationsË«Óï
 CFDA GMP2011Ó¢ÎÄ

 GB50457 -2019¡¶Ò½Ò©¹¤Òµ½à¾»³§·¿Éè¼Æ±ê×¼¡· |
 Å·ÃËGMP2008ÖÐÎÄ |
 ¸½Â¼1 ÎÞ¾úÒ©Æ·Éú²ú 2022ÖÐÓ¢ÎÄаæ New |
 ¸½Â¼3 ·ÅÉäÐÔÒ©Îï New |
 FDA cGMPÖÐÓ¢ÎÄ |
 Ò½ÁÆÆ÷еGMP New |
 ¸ß´¿Ë®ÏµÍ³¼ì²éÖ¸ÄÏ(ÖÐÓ¢ÎÄ)
 ICHÖÐÓ¢ÎÄ |
 Öйú±£½¡Æ·GMP2010 |
 ÊÞ Ò©GMP2020|
 WHO GMP |
 ASTM2500 |
 GSP